Although cystic fibrosis is a single gene mutation, there are more than 1,000 different ways the CFTR gene can mutate in ...
An inhaled gene therapy for cystic fibrosis developed by Boehringer Ingelheim is due to start clinical testing shortly, hoping to become a first-in-class treatment for the genetic disorder.
Boehringer's cystic fibrosis gene therapy is poised to start clinical testing, hoping to offer a one-shot alternative to costly CFTR modulator drugs.
A groundbreaking gene therapy trial for cystic fibrosis (CF) will begin in March, thanks to a new grant from a government funding body. One hundred and thirty adults and children with CF will take ...
Learn how to navigate cystic fibrosis care with confidence, from treatments and school plans to building a supportive medical ...
In March 2025, Vertex Pharmaceuticals Incorporated announced a study is to evaluate the safety, and tolerability and efficacy ...
The genetic condition cystic fibrosis had no treatments on the NHS before 2019 and a Daily Express campaign - now a miracle one-a-day pill could make it vanish.
ReCode Therapeutics, a clinical-stage genetic medicines company using tissue-specific delivery to power the next wave of mRNA ...
A new research project focusing on rare genetic mutations that are linked to cystic fibrosis just received $600,000 in ...
In collaboration with Medical Detection Dogs, a team at Imperial College London has discovered dogs can detect bacteria like ...
The biotech won approval for its first cystic fibrosis (CF) drug -- Kalydeco -- back in 2012 ... collecting approvals for a gene-editing therapy for blood disorders a little over a year ago and a pain ...
Vertex Pharmaceuticals’ triple combination cystic fibrosis (CF) treatment has been approved ... by correcting the malfunctioning protein made by the CFTR gene. The MHRA’s approval of the therapy was ...